Search Results

mTOR function in skeletal muscle: a focal point for overnutrition and exercise

Authors: Rivas, Donato A.; Lessard, Sarah J.; Coffey, Vernon G.

Source: Applied Physiology, Nutrition, and Metabolism, Volume 34, Number 5, 1 October 2009 , pp. 807-816(10)

Publisher: NRC Research Press

Forskolin attenuates the action of insulin on the Akt-mTOR pathway in human skeletal muscle

Authors: Richmond, Scott R.; Touchberry, Chad D.; Gallagher, Philip M.

Source: Applied Physiology, Nutrition, and Metabolism, Volume 34, Number 5, 1 October 2009 , pp. 916-925(10)

Publisher: NRC Research Press

The Multifunctional Role of mTOR in Innate Immunity: Implications for Transplant Immunity

Authors: Säemann, M. D.; Haidinger, M.; Hecking, M.; Hörl, W. H.; Weichhart, T.

Source: American Journal of Transplantation, Volume 9, Number 12, December 2009 , pp. 2655-2661(7)

Publisher: Blackwell Publishing

Variations in the effects on synthesis of amyloid β protein in modulated autophagic conditions

Authors: Makioka, Kouki; Yamazaki, Tsuneo; Kakuda, Satoko; Okamoto, Koichi

Source: Neurological Research, Volume 31, Number 9, November 2009 , pp. 959-968(10)

Publisher: Maney Publishing

CDKs as therapeutic targets for the human genetic disease tuberous sclerosis?

Authors: Rosner, M.; Dolznig, H.; Fuchs, C.; Siegel, N.; Valli, A.; Hengstschläger, M.

Source: European Journal of Clinical Investigation, Volume 39, Number 12, December 2009 , pp. 1033-1035(3)

Publisher: Blackwell Publishing

Vascular endothelial growth factor and mTOR pathways in renal cell carcinoma: differences and synergies of two targeted mechanisms

Author: Mulders, Peter

Source: BJU International, Volume 104, Number 11, December 2009 , pp. 1585-1589(5)

Publisher: Blackwell Publishing

Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer

Authors: Matsuzaki, Taro; Yashiro, Masakazu; Kaizaki, Ryoji; Yasuda, Koichi; Doi, Yosuke; Sawada, Tetsuji; Ohira, Masaichi; Hirakawa, Kosei

Source: Cancer Science, Volume 100, Number 12, December 2009 , pp. 2402-2410(9)

Publisher: Blackwell Publishing

Regulation by FK506 and rapamycin of Ca²⁺ release from the sarcoplasmic reticulum in vascular smooth muscle: the role of FK506 binding proteins and mTOR

Authors: MacMillan, D; McCarron, JG

Source: British Journal of Pharmacology, Volume 158, Number 4, October 2009 , pp. 1112-1120(9)

Publisher: Blackwell Publishing

Translation initiation: a critical signalling node in cancer

Authors: Robert, Francis; Pelletier, Jerry

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 11, November 2009 , pp. 1279-1293(15)

Publisher: Informa Healthcare

Focal brain malformations: Seizures, signaling, sequencing

Author: Crino, Peter B.

Source: Epilepsia, Volume 50, Supplement 9, October 2009 , pp. 3-8(6)

Publisher: Blackwell Publishing

Relationship between expression of mutant type glutathione S-transferase theta-1 gene and reactivity of rapamycin in myelodysplastic syndrome

Authors: Maeda, Yasuhiro; Yamaguchi, Terufumi; Sasakawa, Atsushi; Tanaka, Miyako; Morita, Yasuyoshi; Kawata, Shuhei; Watanabe, Katsuya; Hirase, Chikara; Takai, Shunsuke; Miyatake, Junichi; Tatsumi, Yoichi; Kanamaru, Akihisa

Source: Hematology, Volume 14, Number 5, October 2009 , pp. 266-270(5)

Publisher: Maney Publishing

From mTOR to cognition: molecular and cellular mechanisms of cognitive impairments in tuberous sclerosis

Authors: Ehninger, D.; de Vries, P. J.; Silva, A. J.

Source: Journal of Intellectual Disability Research, Volume 53, Number 10, October 2009 , pp. 838-851(14)

Publisher: Blackwell Publishing

PRAS40: Target or modulator of mTORC1 signalling and insulin action?

Authors: Nascimento, Emmani B.M.; Ouwens, D. Margriet

Source: Archives of Physiology and Biochemistry, Volume 115, Number 4, October 2009 , pp. 163-175(13)

Publisher: Informa Healthcare

Balancing needs and means: the dilemma of the β-cell in the modern world

Authors: Leibowitz, G.; Kaiser, N.; Cerasi, E.

Source: Diabetes, Obesity and Metabolism, Volume 11, Supplement 4, November 2009 , pp. 1-9(9)

Publisher: Blackwell Publishing

Sirolimus: A Novel Immunosuppressive Drug in Heart Transplantation

Authors: Kurian, Kizhake C.; Addisu, Anteneh

Source: Recent Patents on Cardiovascular Drug Discovery, Volume 4, Number 3, November 2009 , pp. 187-191(5)

Publisher: Bentham Science Publishers

Antagonism of the mammalian target of rapamycin selectively mediates metabolic effects of epidermal growth factor receptor inhibition and protects human malignant glioma cells from hypoxia-induced cell death

Authors: Ronellenfitsch, Michael W.; Brucker, Daniel P.; Burger, Michael C.; Wolking, Stefan; Tritschler, Felix; Rieger, Johannes; Wick, Wolfgang; Weller, Michael; Steinbach, Joachim P.

Source: Brain, Volume 132, Number 6, 30 June 2009 , pp. 1509-1522(14)

Publisher: Oxford University Press

Activation of the mammalian target of rapamycin signalling pathway in prostate cancer and its association with patient clinicopathological characteristics

Authors: Dai, Bo; Kong, Yun Yi; Ye, Ding Wei; Ma, Chun Guang; Zhou, XiaoYan; Yao, Xu Dong

Source: BJU International, Volume 104, Number 7, October 2009 , pp. 1009-1016(8)

Publisher: Blackwell Publishing

The PI3K/Akt/mTOR Pathway as Therapeutic Target in Neuroblastoma

Author: Fulda, S.

Source: Current Cancer Drug Targets, Volume 9, Number 6, September 2009 , pp. 729-737(9)

Publisher: Bentham Science Publishers

Enhancing mTOR-targeted cancer therapy

Authors: Wang, Xuerong; Sun, Shi-Yong

Source: Expert Opinion on Therapeutic Targets, Volume 13, Number 10, October 2009 , pp. 1193-1203(11)

Publisher: Informa Healthcare

Targeting the PI3K/AKT/mTOR signaling network in acute myelogenous leukemia

Authors: Martelli, Alberto M; Evangelisti, Camilla; Chiarini, Francesca; Grimaldi, Cecilia; Manzoli, Lucia; McCubrey, James A

Source: Expert Opinion on Investigational Drugs, Volume 18, Number 9, September 2009 , pp. 1333-1349(17)

Publisher: Informa Healthcare